Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 3
2018 1
2019 1
2020 3
2021 1
2022 1
2023 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Immunotolerance in Liver Transplantation.
Mastoridis S, Martinez-Llordella M, Sanchez-Fueyo A. Mastoridis S, et al. Semin Liver Dis. 2017 May;37(2):95-108. doi: 10.1055/s-0037-1602762. Epub 2017 May 31. Semin Liver Dis. 2017. PMID: 28564719 Review. No abstract available.
Regulatory T-cell therapy in liver transplantation.
Whitehouse GP, Hope A, Sanchez-Fueyo A. Whitehouse GP, et al. Transpl Int. 2017 Aug;30(8):776-784. doi: 10.1111/tri.12998. Transpl Int. 2017. PMID: 28608637 Free article. Review.
Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans.
Lim TY, Perpiñán E, Londoño MC, Miquel R, Ruiz P, Kurt AS, Kodela E, Cross AR, Berlin C, Hester J, Issa F, Douiri A, Volmer FH, Taubert R, Williams E, Demetris AJ, Lesniak A, Bensimon G, Lozano JJ, Martinez-Llordella M, Tree T, Sánchez-Fueyo A. Lim TY, et al. J Hepatol. 2023 Jan;78(1):153-164. doi: 10.1016/j.jhep.2022.08.035. Epub 2022 Sep 7. J Hepatol. 2023. PMID: 36087863 Free article. Clinical Trial.
Low-Dose Interleukin-2 for Refractory Autoimmune Hepatitis.
Lim TY, Martinez-Llordella M, Kodela E, Gray E, Heneghan MA, Sanchez-Fueyo A. Lim TY, et al. Hepatology. 2018 Oct;68(4):1649-1652. doi: 10.1002/hep.30059. Hepatology. 2018. PMID: 29698571 No abstract available.
Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation.
Sánchez-Fueyo A, Whitehouse G, Grageda N, Cramp ME, Lim TY, Romano M, Thirkell S, Lowe K, Fry L, Heward J, Kerr A, Ali J, Fisher C, Lewis G, Hope A, Kodela E, Lyne M, Farzaneh F, Kordasti S, Rebollo-Mesa I, Jose Lozano J, Safinia N, Heaton N, Lechler R, Martínez-Llordella M, Lombardi G. Sánchez-Fueyo A, et al. Am J Transplant. 2020 Apr;20(4):1125-1136. doi: 10.1111/ajt.15700. Epub 2020 Feb 3. Am J Transplant. 2020. PMID: 31715056 Free PMC article. Clinical Trial.
IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors.
Whitehouse G, Gray E, Mastoridis S, Merritt E, Kodela E, Yang JHM, Danger R, Mairal M, Christakoudi S, Lozano JJ, Macdougall IC, Tree TIM, Sanchez-Fueyo A, Martinez-Llordella M. Whitehouse G, et al. Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7083-7088. doi: 10.1073/pnas.1620835114. Epub 2017 Jun 5. Proc Natl Acad Sci U S A. 2017. PMID: 28584086 Free PMC article.